Therapies for the world
Virex Pharma is developing novel nanotechnology formulations of an antiviral drug for the treatment of infections caused by Respiratory Syncytial Virus, COVID-19 and Dengue Virus.
CompanyVirex Pharma
Company
Virex Pharma
Virex Pharma is developing novel nanotechnology formulations of an antiviral drug for the treatment of respiratory and encephalitic viral infections.
Product
GlyXine©
Product
GlyXine©
Virex Pharma’s lead formulation is branded as GlyXine and is tailored for delivery into the pulmonary (lungs) system.